Adaptive Agents and Multi-Agent Systems

D. Kudenko,D. Kazakov,E. Alonso

DOI: https://doi.org/10.1007/3-540-44826-8

Abstract:

What problem does this paper attempt to address?

The Effect of Pelvic Floor Magnetic Stimulation in Women with Myofascial Pelvic Pain Syndrome: A Prospective Cohort Pilot Study

Tian Ding,Shuang Zhang,Li Zhao,Yue Wu,Xiu-fang Zhu,Yin-feng Wang,Shuang-shuang Zhong,Zhen-wei Xie

DOI: https://doi.org/10.31083/j.ceog5005100

2023-01-01

Clinical and Experimental Obstetrics & Gynecology

Abstract:Background: Chronic pelvic pain (CPP) is a highly prevalent pain condition in which pelvic floor myofascial pain syndrome (MPPS) is also frequently found. Optimal treatments for CPP and MPPS are unknown. The aims of this pilot study were to investigate the effect of pelvic floor magnetic stimulation (MS) in women with MPPS. Treatment effects were compared between patients receiving MS alone, myofascial release therapy (MRT) alone, and MS + MRT. Methods: Patients were divided into three groups: MS, MRT, and MS + MRT. Questionnaires including Short-form McGill Pain Questionnaire (SF-MPQ), Pelvic Pain and Urgency/Frequency questionnaire (PUF), Female Sexual Function Index (FSFI), Hamilton Anxiety Scale (HAMA), and clinical global impression scale (CGI) were used to assess changes in subjective symptoms before and after treatment. Pelvic floor muscle function was assessed by the Modified Oxford Scale and Surface electromyography (sEMG). Pain mapping was used to locate trigger points (TPs) and to score the intensity of pain. A Visual Analog Scale (VAS) was used to measure the intensity of pain on a scale of 0 to 10. Changes in the above evaluation indexes within each group and between groups were evaluated after 5 treatment sessions and 10 treatment sessions. Results: Nineteen patients completed the treatment between November 2020 and August 2021. The SF-MPQ and PUF scores decreased significantly (p < 0.01) after treatment. The VAS score for pelvic floor tenderness also decreased significantly after 5 and 10 treatment sessions (p < 0.01). At the end of 10 sessions, the HAMA score was significantly lower than prior to treatment (p < 0.01). Conclusions: This preliminary study shows that MS is effective for the treatment of MPPS. Clinical Trial Registration: ChiCTR2000030881.
Fluoxetine Ameliorates Symptoms of Refractory Chronic Prostatitis/chronic Pelvic Pain Syndrome.

Xia Dan,Wang Ping,Chen Jun,Wang Shuo,Jiang Hai

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2011.14.014

2011-01-01

Abstract:Background Category III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common syndrome of unclear etiology with significant impact on quality of life. Because the outcomes of multiple therapies for CP/CPPS have been far from approving, the possible psychological factors have been considered to play an important role in CP/CPPS. Based on this, we investigated the role of antidepressant drug (fluoxetine) in men with refractory CP/CPPS. Methods In this study, 42 men diagnosed with refractory CP/CPPS without response to standard therapy (include multiple antibiotic courses and alpha-blockers) were referred for fluoxetine therapy. All patients received fluoxetine (20 mg/d) for three months and were clinically evaluated before (baseline), and after 4, 8 and 12 weeks of therapy. The evaluation included a National Institutes of Health-chronic prostatitis symptom index (NIH-CPSI) and a Beck depression inventory (BDI) questionnaire. Moreover, the subjective global assessment (SGA) was assessed at the 4th, 8th and 12th week of therapy. Results Significant decreases were observed for total NIH-CPSI (28.55 to 9.29), NIH-CPSI pain (14.69 to 5.19), NIH-CPSI urinary (4.95 to 1.88), NIH-CPSI quality of life (8.83 to 2.20), and BDI (34.67 to 13.95) scores compared with baseline, all P values < 0.05. Twenty-nine (69.05%) reported marked improvement on the subjective global assessment and 33 (78.57%) had a greater than 50% decrease in NIH-CPSI at the end of therapy (12th week). At the same time, the Pearson correlation coefficient analysis demonstrated a positive correlation between BDI score and each CPSI score. No adverse events were reported in this study. Conclusions Fluoxetine appears to be a safe and effective treatment in improving symptoms in, and the quality of life of, men with difficult CP/CPPS. Moreover, amelioration of difficult CP/CPPS-related symptoms could be related to a decrease in depressive symptoms. Chin Med J 2011;124(14):2158-2161
[The regional differences of the pH-value in the vagina, cervix, and uterus of cows during interestrus].

A. Wehrend,K. Trasch,K. Failing,H. Bostedt

2003-02-01

Abstract:This study aimed to ascertain the pH value of the vagina, cervix, and uterus in cows during interoestrus. Measurements were made with an ambulant, digital pH meter with a flexible probe and a measuring frequency of one value per second. The genital tract (vagina, cervix, uterus) of 50 cows were analyzed with this instrument immediately post mortem. The sexual health of the animals was evaluated via clinical, histological, and microbiological tests. Statistically significant regional differences in the pH value were documented (p < 0.01). Whereas a decrease was measured between the values for the vagina (6.92 +/- 0.51) and the cervix (6.22 +/- 0.31), increased values were measured in the uterus (6.62 +/- 0.32). The physiological pH value in the genital tract of the cow should be taken into consideration for the development of new therapeutic measures in terms of the local application of probiotically active bacterial strains.
The effectiveness of non-steroidal anti-inflammatory drugs in the treatment of chronic pelvic pain syndrome

T.G. Romanenko,O.M. Sulimenko,,

DOI: https://doi.org/10.15574/hw.2018.133.111

2018-09-30

HEALTH OF WOMAN

Abstract:Evidence-based medicine is an approach to medical practice in which the decision on the appointment of therapeutic, diagnostic or preventive measures is based on the evidence of their effectiveness and safety. The objective: assessment of the effectiveness and safety of the use of NSAIDs in the treatment of chronic pelvic pain in women of reproductive age. Materials and methods. Under our supervision, there were 101 women of reproductive age with chronic pelvic pain syndrome (CPPS) on the background of chronic inflammatory processes of the pelvic organs. Patients, depending on the received treatment, were randomly divided into two groups: Group I (n=54) – complex antibiotic (AB) therapy was conducted in combination with antiplatelet agents, antihypoxants, analgesics; Group II (n=47) – complex antibiotic (AB) therapy was performed in combination with antiplatelet agents, antihypoxants and NSAIDs (DICLOSAFE, diclofenac sodium 100 mg). The exclusion criterion was the presence of an endometriosis in a patient. When patients were included in the study and 6 months after the completion of the treatment, a questionnaire was conducted to determine the severity of the pain syndrome, psychological status and quality of life. Results. Positive dynamics of quantitative and qualitative characteristics of the pain syndrome, as well as dynamics of its intensity as a result of conservative treatment for 6 months in group ІІ, was noted. Also, in group ІІ, statistically significant data on the reduction of depression and personal anxiety are noted, in contrast to the indicators of group I. The results of the questionnaire of patients in group II after treatment indicated improvement of all components of physical health. Statistically significant differences with the indicators of Group I were obtained on the scale of the effect of pain on daily activity (BP). In addition, after treatment in the II group, the patients showed statistically significant changes in mental health and all its components: vital activity (VT), social activity (SF), limitation of daily activity due to emotional problems (RE) and mental health I (MH). Conclusion. Pathogenetically grounded use of NSAIDs (DICLOSAFE suppositories) in the complex treatment of patients with CPPS allows to achieve a significant improvement in quality of life indicators due to the correction of pain syndrome. Key words: chronic pelvic pain syndrome, treatment, nonsteroidal anti-inflammatory drugs.
Short and long-term effectiveness of external shock wave therapy for chronic pelvic pain syndrome in men

Kareim Khalafalla,Ahmed Albakr,Walid El Ansari,Ahmad Majzoub,Haitham Elbardisi,Khalid AlRumaihi,Mohamed Arafa

DOI: https://doi.org/10.1080/2090598X.2023.2207415

2023-05-16

Arab Journal of Urology

Abstract:Chronic pelvic pain syndrome (CPPS) is a frequent urological diagnosis that affects men's quality of life. Extracorporeal shockwave therapy (ESWT) is a recent treatment option for patients with CPPS. We evaluated ESWT's short and long – term efficacy in managing CPPS. This prospective self-controlled study included 75 patients diagnosed with CPPS at our tertiary pelvic pain clinic between January 2017-June 2019. Patients were referred for ESWT and received four sessions one week apart. The National Institute for Health – Chronic Prostatitis Symptom Index (NIH – CPSI) questionnaire was used to assess patients' symptom severity before starting therapy and at 0, 12 and 26 weeks after completing ESWT. Demographics, clinical data and complications were also recorded. Patients' mean age was 37.9 ± 8.6 years, and mean duration of symptoms was 5 ± 4.5 years. Compared to pre-treatment scores, all patients exhibited improvements across all NIH – CPSI domains directly after completing ESWT (week 0 post-treatment), with a mean difference improvement of 9.26 ± 5.7, 5.2 ± 3.4, 1.19 ± 2.18 and 2.88 ± 2.46 points in the total, pain, urinary symptoms, and quality-of-life scores respectively. At 12 weeks after completing ESWT, 80.9% of patients reported improvements, with mean difference improvement of 8.07 ± 7.56, 4.55 ± 4.6, 0.76 ± 2.48, 2.85 ± 2.78 in the total, pain, urinary symptoms, and quality-of-life scores respectively. Again, none of the patients developed any treatment-related complications. At 26 weeks after completing ESWT, 82.4% of patients reported improvements, with mean difference improvement of 8.29 ± 7.7%, 4.92 ± 4.69, 0.75 ± 2.96, 2.5 ± 3.0 in total, pain, urinary symptoms, and quality-of-life scores respectively. None of the patients developed treatment-related complications. ESWT is a safe and effective treatment modality for patients with CPPS, with short-term improvement in total, pain, urinary symptom, and quality-of-life scores; and long-term improvement in total, pain, and quality-of-life scores.
Diversity and molecular characterization of novel hemoplasmas infecting wild rodents from different Brazilian biomes.

L. R. Gonçalves,A. L. R. Roque,Carlos António Matos,S. D. Fernandes,Isabella Delamain Fernandez Olmos,R. Z. Machado,M. André

DOI: https://doi.org/10.1016/j.cimid.2015.10.006

2015-12-01

Abstract:
Physiotherapy management of patients with chronic pelvic pain (CPP): A systematic review

Susanne G. R. Klotz,Mila Schön,Gesche Ketels,Bernd Löwe,Christian A. Brünahl

DOI: https://doi.org/10.1080/09593985.2018.1455251

2018-03-28

Physiotherapy Theory and Practice

Abstract:INTRODUCTION: Chronic pelvic pain (CPP) is a common pain condition. However, treatment remains challenging. Musculoskeletal findings are frequent; therefore physiotherapy might be helpful. The purpose of this review was to evaluate the current evidence on physiotherapy in patients with CPP (PROSPERO registration number CRD42016037516).METHODS: Six databases were searched and additional hand searches were performed. Two reviewers independently conducted the database search and selected studies using a two-step approach. The methodological quality was assessed applying the Critical Review Form - Quantitative Studies.RESULTS: A total of eight studies were included. Trigger point therapy was examined in four studies; two of which were randomized controlled trials. All studies indicate a significant change in pain measurement. The other four studies evaluated the effect of biofeedback, Thiele massage, Mensendieck somatocognitive therapy and aerobic exercises, whereas the last two were tested in controlled trials. All studies showed significant improvements in pain assessment.CONCLUSIONS: The evidence currently available is sparse with methodological flaws, making it difficult to recommend a specific physiotherapy option. There is an urgent need for high-quality randomized controlled trials to identify the most effective physiotherapy management strategy for patients with CPP.

rehabilitation
Psychological management of patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review

Arthur Sone-Wai Li,Leesa Van Niekerk,Aquina Lim Yim Wong,Mandy Matthewson,Michael Garry

DOI: https://doi.org/10.1515/sjpain-2022-0049

2022-08-09

Scandinavian Journal of Pain

Abstract:Objectives Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a complex condition. Despite recommendations for the inclusion of non-pharmacological treatment in the management of CP/CPPS, the focus has predominantly been on the inclusion of physical therapies with minimal discussion of psychological interventions. Therefore, this systematic review aimed to evaluate peer-reviewed studies of psychological interventions for men with CP/CPPS to determine their therapeutic efficacy and quality of intervention. Methods The review was registered in PROSPERO and based on PRISMA 2020 protocol. The systematic literature search was conducted in six databases. Quantitative studies of psychological intervention for adult men with CP/CPPS that provided outcome measures of pain, quality of life and/or psychological symptoms were reviewed. The Oxford level of evidence and Quality Assessment Tool for Quantitative Studies developed by the Effective Public Health Practice were employed. Results A total of 4,503 studies were reviewed; seven met the inclusion criteria. The included studies were randomised controlled trials, cohort, repeated measures, and case-series studies, with most including combined treatment for CP/CPPS. Cognitive therapy, cognitive behavioural therapy, or paradoxical relaxation training were found to be effective. However, high risks of bias were found in all included studies, limiting the generalisability and reliability of findings. Conclusions Evidence is preliminary but shows promise for psychological treatment either as a combined or standalone treatment for CP/CPPS. However, there is a need to develop research with a more rigorous methodology to evaluate psychological treatments for men with CP/CPPS.
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Juan VA Franco,Tarek Turk,Jae Hung Jung,Yu‐Tian Xiao,Stanislav Iakhno,Virginia Garrote,Valeria Vietto,Yu-Tian Xiao,Juan Va Franco

DOI: https://doi.org/10.1002/14651858.CD012551.pub3

IF: 8.4

2019-10-03

Cochrane Database of Systematic Reviews

Abstract:Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common disorder in which the two main clinical features are pelvic pain and lower urinary tract symptoms. There are currently many approaches for its management, using both pharmacological and non-pharmacological interventions. The National Institute of Health - Chronic Prostatitis Symptom Index (NIH-CPSI) score is a validated measure commonly used to measure CP/CPPS symptoms.

medicine, general & internal
The use of gentian violet 2% solution to identify holes in the deep margin of tissue excised during Mohs micrographic surgery.

T. Shin,J. Etzkorn,J. Sobanko,W. Shaikh,S. Kovach,C. Miller

DOI: https://doi.org/10.1016/j.jaad.2016.11.059

2017-05-01

Abstract:
Chronic Prostatitis/Chronic Pain Pelvic Syndrome and Male Infertility

Andrea Graziani,Giuseppe Grande,Michel Martin,Giordana Ferraioli,Elena Colonnello,Massimo Iafrate,Fabrizio Dal Moro,Alberto Ferlin

DOI: https://doi.org/10.3390/life13081700

2023-08-08

Life

Abstract:Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is defined as urologic pain or discomfort in the pelvic region, associated with urinary symptoms and/or sexual dysfunction, lasting for at least 3 of the previous 6 months. The rate of symptoms related to prostatitis has a mean prevalence of 8–8.2%. CP/CPPS is most frequent in men younger than 50 years, among whom it is the most common urologic diagnosis. In the last decades, many studies have been published on CP/CPPS and its association with male infertility. The pathophysiologic relation between CP/CPPS and male infertility involves several aspects, which are not well studied yet. A reduction in semen parameters has been demonstrated in patients with CP/CPPS, and several mechanisms have been proposed to represent putative pathophysiological links between CP/CPPS and infertility, including male accessory gland inflammation, metabolic syndrome, inflammatory bowel disease, HPV co-infection and autoimmunity. In light of this evidence, a multidisciplinary approach is advocated for patients with known CP/CPPS, and particular attention is needed for male patients of infertile couples in order to evaluate male accessory glands correctly. In addition, it is advisable that future studies dealing with the treatment of CP/CPPS take into consideration all the different pathophysiological aspects implicated.

biology
The Influence of Chronic Prostatitis and Chronic Pelvic Pain Syndrome on Sexual Function in Iraqi Men

Ali Hadi Sabhan,Abbas Sabbar Dakhil

DOI: https://doi.org/10.54133/ajms.v5i.243

2023-09-28

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )

Abstract:Background: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a bothersome disease that affects men and is associated with adverse impacts on their sexual activity and quality of life. Objective: Assessment of sexual dysfunction in Iraqi men with chronic prostatitis. Methods: This study comprised two groups: the first included 112 patients with CP/CPPS, and the second involved 64 healthy volunteers. Assessment of prostatitis symptoms was done using the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Sexual dysfunction was addressed using the International Index of Erectile Function-5 (IIEF-5) questionnaire for assessment of erectile dysfunction severity, the Premature Ejaculation Diagnostic Tool Questionnaire (PEDT) for premature ejaculation, and two questions from the Ejaculatory Function Questionnaire, questions 3 (EjQ3) and 4 (EjQ4), for painful ejaculation and satisfaction of ejaculation. Results: The mean score of the NIH-CPSI for CP/CPPS patients was higher than for the control group, and the pain or discomfort symptom was the most predominant. ED was reported in 46% of CP/CPPS patients, compared to 39% in the control group. PE was recorded in 49% of the patients versus 25% of the control group. Painful ejaculation was found in 65% of the studied patients with CP/CPPS and in 11% of the healthy control group. Ejaculatory dissatisfaction was evident in 67% and 17% of the patients and control groups, respectively. Conclusion: CP/CPPS is associated with distressing sexual dysfunction in the form of erectile dysfunction, premature ejaculation, and ejaculatory dysfunction that affects men's sexual activity.
Complications of Chronic Prostatitis

Satya Srini Vasan

DOI: https://doi.org/10.1007/s11884-012-0132-0

2012-04-05

Current Bladder Dysfunction Reports

Abstract:Chronic prostatitis (CP) is a pelvic condition in men that needs to be distinguished from other forms of prostatitis, such as acute and chronic bacterial prostatitis. CP is characterized by pelvic or perineal pain lasting longer than 3 months without evidence of urinary tract infection. Symptoms may wax and wane and pain may radiate to the back and perineum, causing discomfort while sitting. Dysuria, frequency, urgency, arthralgia, myalgia, unexplained fatigue, abdominal pain, and burning sensation in the penis may be present. Post-ejaculatory pain, mediated by nerves and muscles, is a hallmark of the condition and serves to distinguish CP/chronic pelvic pain syndrome (CPPS) patients from men with benign prostatic hyperplasia and healthy men. Some patients report low libido, sexual dysfunction, and erectile difficulties. The symptoms of CP/CPPS appear to result from interplay between psychological factors and dysfunction in the immune, neurological, and endocrine systems. Some researchers have suggested that CPPS is a form of painful bladder syndrome/interstitial cystitis (PBS/IC). Therapies shown to be effective in treating IC/PBS (eg, quercetin) have shown some efficacy in CP/CPPS. Recent research has focused on genomic and proteomic aspects of the related conditions. There are no definitive diagnostic tests for CP/CPPS. This is a poorly understood disorder, even though it accounts for 90% to 95% of prostatitis diagnoses. Its peak incidence is in men 35 to 45 years old. In 2007, the National Institute of Diabetes and Digestive and Kidney Diseases began using the umbrella term urologic chronic pelvic pain syndromes to refer to pain syndromes associated with the bladder (eg, IC/PBS) and prostate gland (eg, CP/CPPS). The prognosis for CP/CPPS has improved greatly with the advent of multimodal treatment, including phytotherapy, pelvic nerve myofascial trigger point release, anxiety control, and chronic pain therapy.
Malignancy. Cancer cachexia.

K. Calman

British Journal of Hospital Medicine

Abstract:
The study of selective COX-2 inhibitor in the treatment of chronic pelvic pain syndrome

Hang Yin,Xiaofeng Wang,Wenjun Bai,Yongping Zhao,Bo Yang

DOI: https://doi.org/10.3969/j.issn.1008-0848.2008.07.005

2008-01-01

Abstract:Objective: To investigate the mechanism of Type IIIB CPPS and determine reasonable clinical guidance for treatment of it by comparing the efficacy of COX-2 inhibitor and other drugs. Methods: The total of 87 patients with CPPS were first screened by physical examination, urine and EPS analysis and NIH-CPSI score, and then they were divided randomly into three groups including 27 cases treated with Terazosin (Group I), 29 cases treated with Celecoxib (Group II), and 31 cases treated with Celecoxib and Terazosin(Group III). All patients received drug therapy for 4 weeks. Symptom scores (NIH-CPSI) and urodynamic indexes were evaluated and the expression of COX-2 and PGE 2 in EPS of CPPS patients and normal asymptomatic controls were respectively detected by Western Blot and Enzyme-Linked Immumosorbent Assay pre- and post-treatment. Results: (1)Before treatment, the levels of COX-2 and PGE2 in EPS were significantly higher in treated group than those in normal controls (P<0.05), but no statistical significance was found between each treated group(P>0.05). (2) After treatment, the levels of COX-2 and PGE2 in EPS of treated group were significantly lower than those in EPS of pre-treatment counterparts (P<0.05) but no statistical significance was found between each group (P>0.05). (3)There was a significant difference in NIH-CPSI score of treated group between pre- and post treatment (P<0.05) whereas no significant difference was found between each group. Conclusion: The levels of COX-2 and PGE2 in EPS might play an important role in CPPS and were associated with symptoms of CPPS. All of Selective COX-2 inhibitor and Alpha 1-adrenoceptor antagonist reduced the levels of inflammation factors in EPS. The combination of selective COX-2 inhibitor with alpha 1-adrenoceptor antagonist might improve clinical efficacy for CPPS treatment.
Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Disease or Symptom? Current Perspectives on Diagnosis, Treatment, and Prognosis

Jianzhong Zhang,ChaoZhao Liang,Xuejun Shang,Hongjun Li

DOI: https://doi.org/10.1177/1557988320903200

2020-01-01

Abstract:Definitive diagnosis and selection of effective treatment for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) are frustrations encountered frequently by urology care providers in their practice. Knowledge of etiology and pathophysiology is not sufficient and therapeutic guidelines have not yielded acceptable outcomes and prognoses for both patients and care providers. The authors present updated perspectives on CP/CPPS, including definition, diagnosis, treatment, and prognosis, based on literature review and clinical experience. A key point is to shift the diagnostic and therapeutic focus from a single entity of disease toward associated symptoms of CP/CPPS. An individualized multimodal treatment approach to cope with the course of the disorder is proposed. Communications and personal/family/community supports are emphasized as an important component in the therapeutic regime and rehabilitation of patients with CP/CPPS. The purpose is to improve comprehension on CP/CPPS and to help care providers and patients to achieve the goal of medical intervention—relieving associated symptoms of CP/CPPS and improving the quality of life.
Sexual and relationship functioning in men with chronic prostatitis/chronic pelvic pain syndrome and their partners

Kelly B Smith,Caroline F Pukall,Dean A Tripp,J Curtis Nickel

DOI: https://doi.org/10.1007/s10508-006-9086-7

Abstract:This study compared the sexual and relationship functioning of 38 male patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) to that of their female partners, and of both the men and women in these couples to those in 37 control couples. Male sexual function was also examined as a predictor of partner sexual function. In comparison to control males, the men with CP/CPPS reported significantly more sexual dysfunction and symptoms of depression. Furthermore, symptoms of depression mediated the relationship between some aspects of sexual function and male participant status as a patient or control. However, men with CP/CPPS did not report significantly decreased sexual satisfaction or relationship functioning compared to controls. Partners of men with CP/CPPS reported significantly more pain upon intercourse, vaginismus, and depressive symptoms when compared to control females. In addition, patients with CP/CPPS and their partners did not differ significantly from each other with regard to sexual functioning and satisfaction, relationship functioning, and symptoms of depression. Patient sexual functioning significantly predicted female partner sexual functioning. This study was the first to evaluate partners of men with CP/CPPS. Patients and partners in this study reported lower levels of sexual functioning in some domains, yet were comparable to control couples on measures of satisfaction and relationship functioning. Furthermore, the sexual and relationship functioning of patients and partners was significantly associated. The results of this study have implications for the assessment and management of CP/CPPS and for future research in this area.
Biopsychosocial Approaches for the Management of Female Chronic Pelvic Pain: A Systematic Review

Selina Johnson,Alison Bradshaw,Rebecca Bresnahan,Emma Evans,Katie Herron,Dharani K. Hapangama

DOI: https://doi.org/10.1111/1471-0528.17987

2024-10-29

BJOG An International Journal of Obstetrics & Gynaecology

Abstract:Background/Objective Current guidelines recommend biopsychosocial‐informed treatment for chronic pelvic pain (CPP). The objective of this systematic review was to describe the available biopsychosocial approaches for the treatment of CPP, and the outcomes reported, to understand how guideline‐recommended treatments can be applied. Search Strategy MEDLINE, CINAHL, PsycINFO, EMBASE, Emcare, AMED and Cochrane trial registries were searched (inception to 17 November 2023). Selection Criteria CPP Studies in women where the principal treatment modality was a biopsychosocial approach were included. Prospero registration: CRD42022374256. Data Collection/Analysis Data extraction included study setting, population, study design, intervention characteristics and outcome measures and is described via a narrative synthesis. Results The review included 14 RCTs (871 patients) and identified four broad intervention categories (Acceptance Commitment Therapy n = 2, Cognitive Behavioural Therapy n = 6, Mindfulness‐based approaches n = 2, and Physiotherapy‐based interventions n = 4). Pain science education (PSE) and, exposure/engagement with valued activity were recognised as important aspects of treatment regardless of intervention type. The most utilised outcomes were pain reduction and emotional functioning, with all studies reporting improvements in these domains. Heterogeneity in outcomes prevented efficacy comparison. High risk of bias was identified in six studies (1/4 physiotherapy‐based approaches, 2/6 CBT, 1/2 ACT and 2/2 mindfulness‐based interventions). Conclusions CBT and ACT‐based biopsychosocial approaches were found effective in reducing pain and improving psychometric outcomes for CPP. Evaluation indicated PSE, and exposure/engagement in valued activity are important components of biopsychosocial management. Outcome heterogeneity needs to be addressed in future trials.

obstetrics & gynecology
Pelvic venous congestion syndrome: female venous congestive syndromes and endovascular treatment options

Elika Kashef,Elizabeth Evans,Neeral Patel,Deepsha Agrawal,Anne P Hemingway

DOI: https://doi.org/10.1186/s42155-023-00365-y

2023-04-20

CVIR Endovascular

Abstract:Abstract Pelvic venous congestion syndrome (PVCS) is a common, but underdiagnosed, cause of chronic pelvic pain (CPP) in women. PVCS occurs usually, but not exclusively, in multiparous women. It is characterized by chronic pelvic pain of more than six months duration with no evidence of inflammatory disease. The patients present to general practitioners, gynaecologists, vascular specialists, pain specialists, gastroenterologists and psychiatrists. Pain of variable intensity occurs at any time but is worse in the pre-menstrual period, and is exacerbated by walking, standing, and fatigue. Post coital ache, dysmenorrhea, dyspareunia, bladder irritability and rectal discomfort are also common. Under-diagnosis of this condition can lead to anxiety and depression. A multidisciplinary approach in the investigation and management of these women is vital. Non-invasive imaging (US, CT, MRI) are essential in the diagnosis and exclusion of other conditions that cause CPP as well in the definitive diagnosis of PVCS. Trans-catheter venography remains the gold standard modality for the definitive diagnosis and is undertaken as an immediate precursor to ovarian vein embolization (OVE). Conservative, medical and surgical management strategies have been reported but have been superseded by OVE, which has a reported technical success rates of 96–100%, low complication rates and long-term symptomatic relief in between 70–90% of cases. The condition, described in this paper as PVCS, is referred to by a wide variety of other terms in the literature, a cause of confusion. There is a significant body of literature describing the syndrome and the excellent outcomes following OVE however the lack of prospective, multicentre randomized controlled trials for both investigation and management of PVCS is a significant barrier to the complete acceptance of both the existence, investigation and management of the condition.
Clinical efficacy of magnetic vibration magnetoelectric therapy in the treatment of chronic prostatitischronic pelvic pain syndrome

Zi-Heng Zhang,Feng-Juan Chang,Yun Chen

DOI: https://doi.org/10.12998/wjcc.v12.i19.3837

2024-07-06

World Journal of Clinical Cases

Abstract:BACKGROUND The prominent symptoms of chronic pelvic pain syndrome (CPPS) are urogenital pain, lower urinary tract symptoms, psychological problems, and sexual dysfunction. Traditional pharmacological treatments have poor efficacy and more untoward reaction and complications. Magnetic vibration magnetoelectric therapy is a non-invasive form of physiotherapy. Nevertheless, its effectiveness in improving urinary discomfort and relieving pain in patients requires further exploration. AIM To investigate the clinical efficacy of the magnetic vibration magnetoelectric therapy instrument in the treatment of chronic prostatitis (CP)/ CPPS. METHODS Seventy patients with CP/CPPS were collected from the outpatient clinic and ward of the Department of Male Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, and were treated with magnetic vibration magnetoelectric therapy once a day for a period of 14 d. National Institutes of health-chronic prostatitis symptom index (NIH-CPSI), international index of erectile function 5 (IIEF-5), premature ejaculation diagnostic tool (PEDT), generalized anxiety disorder (GAD), patient health questionnaire, the pain catastrophizing scale (PCS) and traditional Chinese medicine syndrome (TCMS) scores were performed before and after treatment. RESULTS The total effective rate of treatment was 58.5%, and the total NIH-CPSI score, pain symptoms, voiding symptoms, quality of life, IIEF-5, PEDT, GAD, PCS and TCMS scores all decreased significantly (P < 0.05). CONCLUSION Magnetic vibration magnetotherapy is effective in improving urinary discomfort, relieving pain, improving quality of life, improving sexual dysfunction and relieving negative emotions such as anxiety in patients with CP/CPPS.

medicine, general & internal

Adaptive Agents and Multi-Agent Systems

The Effect of Pelvic Floor Magnetic Stimulation in Women with Myofascial Pelvic Pain Syndrome: A Prospective Cohort Pilot Study

Fluoxetine Ameliorates Symptoms of Refractory Chronic Prostatitis/chronic Pelvic Pain Syndrome.

[The regional differences of the pH-value in the vagina, cervix, and uterus of cows during interestrus].

The effectiveness of non-steroidal anti-inflammatory drugs in the treatment of chronic pelvic pain syndrome

Short and long-term effectiveness of external shock wave therapy for chronic pelvic pain syndrome in men

Diversity and molecular characterization of novel hemoplasmas infecting wild rodents from different Brazilian biomes.

Physiotherapy management of patients with chronic pelvic pain (CPP): A systematic review

Psychological management of patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review

Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

The use of gentian violet 2% solution to identify holes in the deep margin of tissue excised during Mohs micrographic surgery.

Chronic Prostatitis/Chronic Pain Pelvic Syndrome and Male Infertility

The Influence of Chronic Prostatitis and Chronic Pelvic Pain Syndrome on Sexual Function in Iraqi Men

Complications of Chronic Prostatitis

Malignancy. Cancer cachexia.

The study of selective COX-2 inhibitor in the treatment of chronic pelvic pain syndrome

Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Disease or Symptom? Current Perspectives on Diagnosis, Treatment, and Prognosis

Sexual and relationship functioning in men with chronic prostatitis/chronic pelvic pain syndrome and their partners

Biopsychosocial Approaches for the Management of Female Chronic Pelvic Pain: A Systematic Review

Pelvic venous congestion syndrome: female venous congestive syndromes and endovascular treatment options

Clinical efficacy of magnetic vibration magnetoelectric therapy in the treatment of chronic prostatitischronic pelvic pain syndrome